A biochemical genomics approach for identifying genes by the activity of their products

Science

Volumn 286, Issue 5442, 1999, Pages 1153-1155

  Martien, Mark R ^a   McCraith, Stephen M ^b   Spinelli, Sherry L ^a   Torres, Francy M ^a   Fields, Stanley ^b   Grayhack, Elizabeth J ^a   Phizicky, Eric M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; GLUTATHIONE TRANSFERASE; METHYLTRANSFERASE; PHOSPHODIESTERASE;

ARTICLE; GENE FUNCTION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PURIFICATION; YEAST;

ADENOSINE DIPHOSPHATE RIBOSE; FUNGAL PROTEINS; GENES, FUNGAL; GENETIC TECHNIQUES; GLUTATHIONE TRANSFERASE; HISTONE-LYSINE N-METHYLTRANSFERASE; OPEN READING FRAMES; PHOSPHORIC DIESTER HYDROLASES; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 0033527694     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.286.5442.1153     Document Type: Article

References (22)

1. H. Simonsen and H. F. Lodish, Trends Pharmacol. Sci. 15, 437 (1994).
2. Plasmid pYEX 4T-1 (Clontech, Palo Alto, CA) was modified by the addition of a 140-nucleotide recombination domain, 3′ of its Eco Rl site, linearized within the recombination domain by restriction digestion, and cotransformed with a genomic set of reamplified ORFs that had the same ends as the linearized plasmid [J. R. Hudson Jr. et al., Genome Res. 7, 1169 (1997) ] into strain EJ 758 [MATa his3-Δ200, leu2-3,112, ura3-52, pep4::URA3], a derivative of JHRY-20-2Ca (5). Transformants obtained on synthetic minimal (SD) - Ura drop-out plates [F. Sherman, Methods Enzymol. 194, 3 (1991)] (>100 in all cases, and more than five times the cut vector in 97% of the cases) were eluted in batch and saved In 96-well microtiter plates. The library contains 6080 ORF-containing strains and 64 strains with vector only.
3. Plasmid pYEX 4T-1 (Clontech, Palo Alto, CA) was modified by the addition of a 140-nucleotide recombination domain, 3′ of its Eco Rl site, linearized within the recombination domain by restriction digestion, and cotransformed with a genomic set of reamplified ORFs that had the same ends as the linearized plasmid [J. R. Hudson Jr. et al., Genome Res. 7, 1169 (1997) ] into strain EJ 758 [MATa his3-Δ200, leu2-3,112, ura3-52, pep4::URA3], a derivative of JHRY-20-2Ca (5). Transformants obtained on synthetic minimal (SD) - Ura drop-out plates [F. Sherman, Methods Enzymol. 194, 3 (1991)] (>100 in all cases, and more than five times the cut vector in 97% of the cases) were eluted in batch and saved In 96-well microtiter plates. The library contains 6080 ORF-containing strains and 64 strains with vector only.
4. 2, 5 mM dithiothreitol (DTT), 10% glycerol, and 1 M NaCl] containing leupeptin (2 μg/ml) and pepstatin (1 μg/ml), and extracts were made with glass beads [S. M. McCraith and E. M. Phizicky, Mol. Cell. Biol. 10, 1049 (1990)] , followed by supplementation with 1 mM phenylmethylsulfonyl fluoride and centrifugation. CST-ORF fusion proteins were purified by glutathione agarose chromatography in buffer containing 0.5 M NaCl, essentially as described [J. R. Nelson, C. W. Lawrence, D. C. Hinkle, Science 272, 1646 (1996)]
5. 2, 5 mM dithiothreitol (DTT), 10% glycerol, and 1 M NaCl] containing leupeptin (2 μg/ml) and pepstatin (1 μg/ml), and extracts were made with glass beads [S. M. McCraith and E. M. Phizicky, Mol. Cell. Biol. 10, 1049 (1990)] , followed by supplementation with 1 mM phenylmethylsulfonyl fluoride and centrifugation. CST-ORF fusion proteins were purified by glutathione agarose chromatography in buffer containing 0.5 M NaCl, essentially as described [J. R. Nelson, C. W. Lawrence, D. C. Hinkle, Science 272, 1646 (1996)]
6. 2, 5 mM dithiothreitol (DTT), 10% glycerol, and 1 M NaCl] containing leupeptin (2 μg/ml) and pepstatin (1 μg/ml), and extracts were made with glass beads [S. M. McCraith and E. M. Phizicky, Mol. Cell. Biol. 10, 1049 (1990)] , followed by supplementation with 1 mM phenylmethylsulfonyl fluoride and centrifugation. CST-ORF fusion proteins were purified by glutathione agarose chromatography in buffer containing 0.5 M NaCl, essentially as described [J. R. Nelson, C. W. Lawrence, D. C. Hinkle, Science 272, 1646 (1996)]
7. C. L. Greer, C. L Peebles, P. Gegenheimer, J. Abelson, Cell 32, 537 (1983); E. M. Phizicky, R. C. Schwartz. J. Abelson J. Biol. Chem. 261, 2978 (1986); E. M. Phizicky, S. A. Consaul, K. W. Nehrke, J. Abelson, J. Biol. Chem. 267, 4577 (1992).
8. C. L. Greer, C. L Peebles, P. Gegenheimer, J. Abelson, Cell 32, 537 (1983); E. M. Phizicky, R. C. Schwartz. J. Abelson J. Biol. Chem. 261, 2978 (1986); E. M. Phizicky, S. A. Consaul, K. W. Nehrke, J. Abelson, J. Biol. Chem. 267, 4577 (1992).
9. C. L. Greer, C. L Peebles, P. Gegenheimer, J. Abelson, Cell 32, 537 (1983); E. M. Phizicky, R. C. Schwartz. J. Abelson J. Biol. Chem. 261, 2978 (1986); E. M. Phizicky, S. A. Consaul, K. W. Nehrke, J. Abelson, J. Biol. Chem. 267, 4577 (1992).
10. S. M. McCraith and E. M. Phizicky, J. Biol. Chem. 266, 11986 (1991); G. M. Culver, S. M. McCraith, S. A. Consaul, D. R. Stanford, E. M. Phizicky J. Biol. Chem. 272, 13203 (1997); S. L. Spinelli, S. A. Consaul, E. M. Phizicky, RNA 3, 1388 (1997).
11. S. M. McCraith and E. M. Phizicky, J. Biol. Chem. 266, 11986 (1991); G. M. Culver, S. M. McCraith, S. A. Consaul, D. R. Stanford, E. M. Phizicky J. Biol. Chem. 272, 13203 (1997); S. L. Spinelli, S. A. Consaul, E. M. Phizicky, RNA 3, 1388 (1997).
12. S. M. McCraith and E. M. Phizicky, J. Biol. Chem. 266, 11986 (1991); G. M. Culver, S. M. McCraith, S. A. Consaul, D. R. Stanford, E. M. Phizicky J. Biol. Chem. 272, 13203 (1997); S. L. Spinelli, S. A. Consaul, E. M. Phizicky, RNA 3, 1388 (1997).
13. G. M. Culver, S. A. Consaul, K. T. Tycowski, W. Filipowicz, E. M. Phizicky, J. Biol Chem. 269, 24928 (1994).
14. G. M. Culver et al., Science 261, 206 (1993).
15. R. J. DeLange, A. N. Glazer, E. L Smith, J. Biol. Chem. 245, 3325 (1970).
16. Crude extract from 430 g of strain JHRY-20-2Ca (5) was chromatographed successively on Blue Sepharose, heparin agarose, hydroxyapatite, and Orange A Sepharose to purify cyclic phosphodiesterase activity 4000-fold in relation to crude extract.
17. C. L. Peebles, P. Gegenheimer, J. Abelson, Cell 32, 525 (1983); C. R. Trotta et al., Cell 89, 849 (1996).
18. C. L. Peebles, P. Gegenheimer, J. Abelson, Cell 32, 525 (1983); C. R. Trotta et al., Cell 89, 849 (1996).
19. S. L Spinelli, R. Kierzek, D. H. Turner, E. M. Phizicky. J. Biol. Chem. 274, 2637 (1999).
20. H. H. Liao and F. Sherman, J. Bacteriol. 138, 853 (1979); H. Morino, T. Kawamoto, M. Miyake, Y. Kakimoto, J. Neurochem. 48, 1201 (1987).
21. H. H. Liao and F. Sherman, J. Bacteriol. 138, 853 (1979); H. Morino, T. Kawamoto, M. Miyake, Y. Kakimoto, J. Neurochem. 48, 1201 (1987).
22. We thank M. Dumont, M. Gorovsky, and L Tabak for comments and B. Pinsky for assistance. Supported by the University of Rochester Medical School and the Merck Genome Research Institute (grant 196 to E.M.P. and E.J.G.), NIH (grant GM52347 to E.M.P.), American Cancer Society (grant RPG-95-049-05-MBC to E.J.G.), the National Center for Research Resources (grant P41 RR11B23 to S.F.), and the Merck Genome Research Institute (to S.F.). S.F. is an investigator of the Howard Hughes Medical Institute.